Legato Capital Management’s ResMed RMD Stock Holding History

Legato Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,297	Closed	-$1.78M	–	226
2020 Q2	$1.78M	Buy	+9,297	New	+$1.52M	0.36%	78

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legato Capital Management's RMD Position: Q3 2020 in Review

Legato Capital Management sold out of ResMed (RMD) in Q3 2020, closing a stake of 9,297 shares — an estimated $1.78M sold.

Legato Capital Management first reported a position in RMD in Q2 2020 and held it in 1 quarter. The position peaked at $1.78M in Q2 2020. 626 funds tracked by Wall St. Rank hold RMD as of Q3 2020.

Legato Capital Management reported no remaining ResMed position as of Q3 2020 after selling out during the quarter.
Legato Capital Management sold 9,297 ResMed shares in Q3 2020, an estimated $1.78M.
Legato Capital Management first reported a position in ResMed in Q2 2020 and held it in 1 quarter.
Legato Capital Management's ResMed position peaked at $1.78M in Q2 2020.
626 funds tracked by Wall St. Rank held ResMed as of Q3 2020.

Based on Legato Capital Management's 13F filing for Q3 2020, filed 13 Oct 2020.